More Checklist for Implementation of GDP Principles - Part 4: Documentation
More FDA Warning Letter: Observed particulates in repackaged drug components
More FDA Warning Letter for Chinese Company based on Review of Records
More VICH: Guideline for Active Pharmaceutical Ingredients in Veterinary Medicinal Products
More EMA: Further Update of the Q&A Documents on "Centralised Procedures"
More EDQM: Addendum 11.5 to the European Pharmacopoeia available
More FDA Revision to the Guidance on Quality Considerations for Ophthalmic Drug Products
More Cloud Computing: Validation performed by a CSP on its own - what is the Value?
More FDA Warning Letter for not answering a Request for Inspection
More India's Health Ministry revises GMP Rules - and replaces the 'GMP' Term
More EMA publishes ICH Q14 Guideline on Analytical Procedure Development - Step 5
More New FDA Warning Letter because of inadequate Quality Oversight